Clinical Trial Update: Evaluation Of Missed Osteoporosis Diagnoses, And Preference Between Once Monthly Ibandronate And Once Weekly Alendronate [Phase 4]

View source ↗

Summary

This Phase 4 trial has completed an evaluation of missed osteoporosis diagnoses and patient preference between once-monthly ibandronate and once-weekly alendron…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Boniva (ibandronate)
• FOSAMAX (ALENDRONATE SODIUM)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Osteoporosis | Phase 4 | Status: COMPLETED